ArticleFrontiers in endocrinology2022

ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.

Yao-Hua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.